
FOOT & ANKLE
Electrolysis demonstrated better plantar heel pain reduction over 6 months follow-up versus placebo
Foot Ankle Int. 2018 Sep;39(9):1039-1046. doi: 10.1177/107110071877399873 patients with chronic plantar heel pain were randomized to five sessions of either treatment with percutaneous needle electrolysis (PNE) or to control with placebo intervention. Patients were assessed for outcome related to first step heel pain on a visual analog scale, the Foot an Ankle Ability Measure (FAAM) Activities of Daily Living (ADL) score, and plantar fascia thickness on ultrasound over 24-week follow-up. After 24 weeks, changes in first step heel pain, FAAM-ADL score, and decrease in plantar fascia thickness all significantly favoured the PNE group compared to the placebo group.
Unlock the full ACE Report
You have access to {0} free articles per month.Click below to unlock and view this {1}
Unlock NowCritical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics
Or upgrade today and gain access to all OrthoEvidence content for just $1.99 per week.
Already have an account? Log in


Subscribe to "The Pulse"
Evidence-Based Orthopaedics direct to your inbox.
{0} of {1} free articles
Become an OrthoEvidence Premium Member. Expand your perspective with high-quality evidence.
Upgrade Now